Alopecia Universalis
📧 Sign up to get email alerts when something new happens for Alopecia Universalis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation
Completed clinical trial evaluating the safety and effectiveness of Rhofanib (tofacitinib) for alopecia areata and its severe forms, alopeci…
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata [Phase 2]
A Phase 2 study of EQ101 in adults with moderate-to-severe alopecia areata has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi. [Phase 3]
A Phase 3 clinical trial evaluated the efficacy of oral tofacitinib for moderate to severe alopecia areata, including alopecia totalis and u…
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: Clinical Application of Stem Cell Educator Therapy in Alopecia Areata [Phase 2]
Phase 2 clinical trial update for Stem Cell Educator Therapy in alopecia areata, investigating alopecia areata, totalis, and universalis.
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT) [Phase 2]
Phase 2 trial for ATI-502 topical solution in alopecia areata, alopecia universalis, and alopecia totalis was terminated; results posted in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis [Phase 2]
Phase 2 trial comparing ATI-501 oral suspension to placebo in subjects with alopecia areata, alopecia universalis, or alopecia totalis has c…
-
CLINICAL_TRIALS trial_result · 2020-07-02Clinical Trial Update: Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT) [Phase 2]
Phase 2 safety and pharmacokinetic study of ATI-50002 in subjects with Alopecia Universalis and Alopecia Totalis has been completed with res…
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata [Phase 2]
Phase 2 open-label study of ATI-50002 topical solution in adults with eyebrow loss due to alopecia areata completed with posted results in 2…
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants [Phase 2]
Phase 2 trial evaluating the safety and efficacy of topical tofacitinib for alopecia areata and its variants (alopecia totalis and alopecia …
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Tofacitinib for the Treatment of Alopecia Areata and Its Variants [NA]
A Stanford-sponsored study (NCT02312882) evaluated tofacitinib for alopecia areata and its variants. The trial status is completed and resul…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Tofacitnib for the Treatment of Alopecia Areata and Variants [Phase 2]
This document reports a completed Phase 2 clinical trial of tofacitinib for alopecia areata and its variants (alopecia totalis and alopecia …
-
CLINICAL_TRIALS trial_result · 2010-07-22Clinical Trial Update: Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata [Phase 4]
Phase 4 trial evaluating the safety and efficacy of an oral Mega Pulse methylprednisolone for severe, therapy-resistant alopecia areata (inc…